Hepatitis C can be cured but can be difficult to spot until it’s caused liver damage.
Academic rigor, journalistic flair
Articles on Hepatitis C
Displaying 1 - 20 of 64 articles
One person still dies every three days in the UK after receiving contaminated blood in the 1970s and ‘80s. This global scandal has has devastated many families, including those with haemophilia
Hepatitis E is a global health problem with about 20 million cases occurring annually, three million symptomatic cases, and 60,000 deaths.
Around 60% of Australians with hepatitis C have accessed treatment which usually cures the condition. But to eliminate the disease, we need to prevent re-infection and tackle stigma.
Climate change, inequality, the evolution of knowledge… Experts have been surveyed, and a consensus is emerging on what to expect from the effects of these factors in the medical field.
Hepatitis C treatments are up to 95% effective when caught early.
Using a Nobel Prize-winning technique called cryo-EM, researchers were able to identify potential areas on the hepatitis C virus that a vaccine could target.
There has been a monumental policy shift in paying blood plasma donors in Canada.
Millions of Americans wear jewelry that pierces the ear, nose, lips, tongue and genital areas. But adorning yourself with metal body art can be a health hazard.
Direct-acting antivirals can cure hepatitis C in eight to 12 weeks. But while the rate of uptake in Australia has slowed, a greater proportion of those undertaking treatment are in prison.
Some cancers are actually caused by viruses that linger for long periods in the body, or cause physical damage that later turns cancerous.
CC BY-NC-ND10.5 MB (download)
New direct-acting antiviral drugs would work successfully in countries where numerous different strains of hepatitis C are found.
Direct-acting antivirals have mostly been used in countries with high incomes. These drugs would be effective against most hepatitis C strains. which are primarily low-income countries.
Michael Houghton, an Edmonton-based virologist, was one of the recipients of this year’s Nobel Prize for physiology or medicine for the discovery of hepatitis C.
The 2020 Nobel Prize for Physiology or Medicine goes to the discoverers of the hepatitis C virus. There’s an effective cure but homelessness and the opioid epidemic are driving a surge in infections.
About 19 million Nigerians have hepatitis but most of them don’t know it.
Proposals in NSW to force someone who spits at or bites a frontline worker to be tested for HIV and other blood-borne viruses are a real problem - for workers and the public.
New research reveals a link between a diagnosis of cancer and a lifetime number of 10 or more sexual partners. But there are some flaws in the research we need to consider in interpreting the results.
Curing thousands of Australians with hepatitis C is one of the public health success stories of recent years. We can take lessons from this as we continue in the fight against hepatitis B.
A new test which capitalises on existing knowledge and technology will increase diagnoses, speed up the process and save the NHS millions of pounds.
Top contributors
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Professor of Viral Hepatitis, University of Glasgow
-
Associate professor, La Trobe University
-
Professor of Internal Medicine, University of Michigan
-
Senior Lecturer, Gastroenterology & Hepatology Unit and Consultant Gastroenterologist & Hepatologist, University of Ibadan
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Associate Professor of Epidemiology & Program Head of Surveillance Evaluation and Research, UNSW Sydney
-
Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Professor and Director of the Centre for Social Research in Health, UNSW Sydney
-
Deputy Director, Burnet Institute, Adjunct Professor, Monash University, Burnet Institute
-
Professor of Health and Ethnicity, University of East London
-
Professor and Executive Dean of School, Medical and Health Sciences, Edith Cowan University
-
Research Associate, University of Bristol
-
Senior Lecturer, School of Medical Sciences, Edith Cowan University
